Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001130319-07-000052
Filing Date
2007-02-05
Accepted
2007-02-05 17:26:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-10 o34619fv10.htm F-10 357348
2 CONSENT OF ERNST & YOUNG LLP DATED FEBRUARY 5, 2007 o34619exv5w1.htm EX-5.1 2061
3 CONSENT OF BENNETT JONES LLP DATED FEBRUARY 5, 2007 o34619exv5w2.htm EX-5.2 2831
4 CONSENT OF FASKEN MARTINEAU DUMOULIN LLP DATED FEBRUARY 5, 2007 o34619exv5w3.htm EX-5.3 2415
5 GRAPHIC o34619o3461700.gif GRAPHIC 1920
6 GRAPHIC o34619o3461701.gif GRAPHIC 8884
  Complete submission text file 0001130319-07-000052.txt   381232
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-140460 | Film No.: 07581619
SIC: 2834 Pharmaceutical Preparations